Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).
Richard S. Finn(University of California, Los Angeles), Jordi Bruix(Hospital Clínic de Barcelona), Özlem Anak, R. T. P. Poon, H.-J. Klümpen(Erasmus MC Cancer Institute), Tanya Paquet, Yibin Kang(Rutgers, The State University of New Jersey), L. Chen, Tiffany Kunz, Kobby Asubonteng(AstraZeneca (United States)), Dalila Sellami(Daiichi Sankyo (United States)), Carlos Gómez-Martín(Hospital Universitario 12 De Octubre), T. Kim, Thomas Yau(University of Hong Kong), Robert Winkler
Cited by 17
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k